Genscript Biotech Corporation
GNNSF | OTC
$4.50
$0.00 (0.00%)
At close: Oct 28, 2026, 9:30 AM ET
$4.50
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 5:00 PM ET
Market Data
Market Cap $10.12B
Enterprise Value $9.54B
Beta 0.85
Average Volume 1.2K
Shares Outstanding (Diluted) 2.19B
Shares Change YoY 3.25%
Institutional Ownership N/A
Exchange OTC
ISIN KYG3825B1059
Price Performance
Price Change 1M -18.6%
Price Change 3M 125.0%
Price Change 6M 216.9%
Price Change YTD 171.1%
Price Change 1Y 147.3%
Price Change 3Y 70.5%
Price Change 5Y 2.0%
1M CAGR (ann.) 9.8%
1Y CAGR (ann.) 109.3%
5Y CAGR (ann.) 15.9%
All-Time CAGR 19.5%
Valuation
PE Ratio -15.52
Forward PE 51.21
PEG Ratio 0.00
Forward PEG 0.13
PS Ratio 11.99
Forward PS 8.60
PB Ratio 2.60
P/FCF Ratio 201.20
P/Adj. FCF Ratio 224.49
P/OCF Ratio 64.29
EV/Sales 11.31
EV/EBIT 75.99
EV/EBITDA 48.09
EV/FCF 189.74
Earnings Yield -6.4%
FCF Yield 0.5%
Adj. FCF Yield 0.5%
Financial Health
Net Cash $537.94M
Total Debt $254.68M
Cash & Short-Term Investments $831.18M
Total Assets $4.79B
Current Ratio 1.48
Quick Ratio 1.42
Debt / Equity Ratio 0.07
Debt / EBITDA 1.28
Debt / FCF 5.06
OCF / Debt 0.59
Interest Coverage 8.67
Altman Z-Score 7.73
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 52.0%
Operating Profit Margin 14.9%
EBITDA Margin 24.3%
Net Profit Margin -75.4%
FCF Margin 6.0%
Adj. FCF Margin 5.3%
SBC / Revenue 0.6%
SBC Impact (per share) -10.4%
Returns
Return on Assets -13.3%
Return on Equity -16.2%
Return on Invested Capital 3.0%
Return on Capital Employed 3.1%
Return on Tangible Assets -13.3%
Historical Growth (CAGR)
Revenue CAGR 3Y 38.5%
Revenue CAGR 5Y 53.6%
Revenue CAGR 10Y 27.2%
EPS CAGR 3Y -28.5%
EPS CAGR 5Y -45.9%
EPS CAGR 10Y -24.8%
FCF CAGR 3Y 91.4%
FCF CAGR 5Y 22.8%
FCF CAGR 10Y 34.0%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Mar 24, 2027
EPS Estimate (next Q) $0.01
EPS Growth Est (next Q) -104.3%
Revenue Est (next Q) $495.8M
Revenue Growth Est (next Q) 12.5%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $0.00
Price Target Upside N/A
Cash Flow
Operating Cash Flow $149.59M
Free Cash Flow $50.3M
Adj. Free Cash Flow $45.08M
FCF Per Share $0.02
OCF Per Share $0.07
OCF/S Ratio 17.7%
Income Statement
Revenue $844M
Gross Profit $438.79M
Operating Income $125.59M
EBITDA $198.44M
Net Income $-636.4M
EPS (Diluted) -$0.29
Revenue / Employee $136.9K
Profit / Employee $-103.23K
Employees 6,165
Add to Watchlist
Select watchlists to add or remove GNNSF